美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Turn Therapeutics (Direct Listing)

3.50

-0.5000-12.50%

盤前：3.500.00000.00%04:25 EST

成交量：9.48萬

成交額：34.23萬

市值：1.03億

市盈率：-37.21

高：3.98

開：3.98

低：3.40

收：4.00

52周最高：26.50

52周最低：3.40

股本：2,944.52萬

流通股本：1,786.88萬

量比：1.22

換手率：0.53%

股息：- -

股息率：- -

每股收益(TTM):-0.0941

每股收益(LYR):-0.0659

淨資產收益率：-341.26%

總資產收益率：-58.09%

市淨率：58.08

市盈率(LYR):-53.13

資料載入中...

總覽公司新聞資訊公告

Turn Therapeutics 任命資本市場資深專家 Andrew Scott 為企業傳播副總裁

Turn Therapeutics與領先的醫用外科產品製造和分銷商Medline簽署全球供應、開發和許可協議

Turn Therapeutics發佈股東更新，強調在臨牀和戰略里程碑上的持續進展

Turn Therapeutics任命Arthur Golden為董事會成員

異動解讀 | Turn Therapeutics股東擬拋售股票，盤後大跌5.43%

Turn Therapeutics提交招股書，涉及股東分批出售最多700萬股股票

美股異動 | 次新股Turn Therapeutics(TTRX.US)漲超144% 致力於開發下一代皮膚病、傷口和抗感染療法

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TTRX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TTRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TTRX\",,,,,undefined,":{"symbol":"TTRX","market":"US","secType":"STK","nameCN":"Turn Therapeutics (Direct Listing)","latestPrice":3.5,"timestamp":1763413200000,"preClose":4,"halted":0,"volume":94773,"hourTrading":{"tag":"盘前","latestPrice":3.5,"preClose":3.5,"latestTime":"04:25 EST","volume":12,"amount":42,"timestamp":1763457959178},"delay":0,"floatShares":17868800,"shares":29445200,"eps":-0.094066,"marketStatus":"盤前交易","change":-0.5,"latestTime":"11-18 07:57:30 EST","open":3.98,"high":3.98,"low":3.4,"amount":342251.3181885,"amplitude":0.145,"askPrice":3.79,"askSize":100,"bidPrice":3.3,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.094066,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1763476200000},"marketStatusCode":1,"adr":0,"listingDate":1759896000000,"exchange":"NASDAQ","adjPreClose":3.5,"preHourTrading":{"tag":"盘前","latestPrice":3.5,"preClose":3.5,"latestTime":"04:25 EST","volume":12,"amount":42,"timestamp":1763457959178},"postHourTrading":{"tag":"盘后","latestPrice":3.4309,"preClose":3.5,"latestTime":"19:45 EST","volume":855,"amount":2952.7476,"timestamp":1763426736190},"volumeRatio":1.2166294356852128},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TTRX\",,,,,undefined,":{"symbol":"TTRX","floatShares":17868800,"roa":"-58.09%","roe":"-341.26%","lyrEps":-0.065873,"volumeRatio":1.2166294356852128,"shares":29445200,"dividePrice":0,"high":3.98,"amplitude":0.145,"preClose":4,"low":3.4,"week52Low":3.4,"pbRate":"58.08","week52High":26.5,"institutionHeld":0,"latestPrice":3.5,"committee":0.333333,"eps":-0.094066,"divideRate":0,"volume":94773,"delay":0,"ttmEps":-0.094066,"open":3.98,"prevYearClose":10,"prevWeekClose":4,"prevMonthClose":4.85,"prevQuarterClose":10,"fiveDayClose":4.13,"twentyDayClose":4.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TTRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TTRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TTRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TTRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TTRX","date":"2025-11-17","current":-37.207918,"percent":0.962963,"low":-100.764104,"twenty":-60.064168,"median":-54.160706,"eighty":-46.088625,"high":-42.496165,"avg":-56.020695,"sd":12.901792,"marketCap":112091304},"quantilePoints":[{"date":"2025-10-10","current":-100.764104,"twenty":-95.944951,"median":-88.716222,"eighty":-81.487493,"marketCap":257809999},{"date":"2025-10-17","current":-61.772777,"twenty":-80.611283,"median":-71.301556,"eighty":-62.49565,"marketCap":158048738},{"date":"2025-10-24","current":-54.215469,"twenty":-75.594983,"median":-58.815569,"eighty":-54.127848,"marketCap":138712988},{"date":"2025-10-31","current":-57.391729,"twenty":-70.118673,"median":-57.391729,"eighty":-54.25928,"marketCap":146839608},{"date":"2025-11-07","current":-46.548635,"twenty":-64.664269,"median":-55.529784,"eighty":-49.111548,"marketCap":119097010},{"date":"2025-11-14","current":-44.796216,"twenty":-60.918473,"median":-54.215469,"eighty":-46.701972,"marketCap":114613358},{"date":"2025-11-17","current":-43.81048,"twenty":-60.064168,"median":-54.160706,"eighty":-46.088625,"marketCap":112091304}],"updateTime":1763470651017},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TTRX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1112036493","title":"Turn Therapeutics 任命資本市場資深專家 Andrew Scott 為企業傳播副總裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1112036493","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112036493?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 06:09","pubTimestamp":1762294167,"startTime":"0","endTime":"0","summary":"Turn Therapeutics 任命资本市场资深专家 Andrew Scott 为企业传播副总裁","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1103328553","title":"Turn Therapeutics與領先的醫用外科產品製造和分銷商Medline簽署全球供應、開發和許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1103328553","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103328553?lang=zh_tw&edition=fundamental","pubTime":"2025-10-30 19:31","pubTimestamp":1761823868,"startTime":"0","endTime":"0","summary":"Turn Therapeutics与领先的医用外科产品制造和分销商Medline签署全球供应、开发和许可协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1148388176","title":"Turn Therapeutics發佈股東更新，強調在臨牀和戰略里程碑上的持續進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1148388176","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148388176?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 20:03","pubTimestamp":1761134630,"startTime":"0","endTime":"0","summary":"Turn Therapeutics发布股东更新，强调在临床和战略里程碑上的持续进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1150228317","title":"Turn Therapeutics任命Arthur Golden為董事會成員","url":"https://stock-news.laohu8.com/highlight/detail?id=1150228317","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150228317?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 00:09","pubTimestamp":1760458140,"startTime":"0","endTime":"0","summary":"加利福尼亚州韦斯特莱克村，2025年10月14日——Turn Therapeutics是一家处于临床阶段的生物技术公司，专注于开发下一代皮肤病学、创伤护理和抗感染疗法。公司宣布任命Arthur Golden为董事会成员，他是一位资深企业董事会顾问，在并购交易、股东关系、合规和治理方面拥有丰富经验。他拥有数十年的企业董事经验，最近担任Emerson Electric董事24年，并担任企业治理和财务委员会主席，同时是执行委员会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX","BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"1135785184","title":"異動解讀 | Turn Therapeutics股東擬拋售股票，盤後大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135785184","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135785184?lang=zh_tw&edition=fundamental","pubTime":"2025-10-10 04:34","pubTimestamp":1760042075,"startTime":"0","endTime":"0","summary":"周四盘后交易时段，Turn Therapeutics（股票代码：TTRX）股价大幅下跌5.43%，引发投资者关注。\n\n消息面上，Turn Therapeutics于当日提交了一份招股说明书，披露公司股东计划分批出售最多700万股股票。这一举动可能会增加市场上流通的股票数量，从而对股价造成压力。\n\n分析人士指出，股东大规模减持往往被市场视为对公司未来发展缺乏信心的信号。此外，增加的股票供给可能会导致股价下跌。投资者对这一消息反应强烈，导致Turn Therapeutics股价在盘后交易中出现显著跌幅。然而，具体影响还需进一步观察，因为实际售股数量和时间表尚未确定。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TTRX"],"gpt_icon":0},{"id":"1171585948","title":"Turn Therapeutics提交招股書，涉及股東分批出售最多700萬股股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1171585948","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171585948?lang=zh_tw&edition=fundamental","pubTime":"2025-10-10 04:18","pubTimestamp":1760041095,"startTime":"0","endTime":"0","summary":"Turn Therapeutics提交招股书，涉及股东分批出售最多700万股股票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"2574255164","title":"美股異動 | 次新股Turn Therapeutics(TTRX.US)漲超144% 致力於開發下一代皮膚病、傷口和抗感染療法","url":"https://stock-news.laohu8.com/highlight/detail?id=2574255164","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574255164?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 23:51","pubTimestamp":1760025108,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四，次新股Turn Therapeutics(TTRX.US)股价上涨，截至发稿，该股涨超144%，报16.95美元。Turn Therapeutics致力于开发下一代皮肤病、伤口和抗感染疗法。该公司拥有一种专有的递送平台技术 “PermaFusion®”，该技术旨在让水溶性的活性成分在无需乳化剂的情况下，以油性载体渗透进入皮肤、指甲或黏膜，从而增强可用性和减少刺激性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LENZ","BK4007","BK4539","BK4139","TTRX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}